Trials and fast changing technologies: the case for tracker studies

Evaluating treatments is difficult when developments or variants arise frequently. In these circumstances randomized controlled trials should not await stability, but should track progress over time, providing unbiased comparisons at each stage.

Saved in:
Bibliographic Details
Published inBMJ Vol. 320; no. 7226; pp. 43 - 46
Main Authors Lilford, Richard J, Braunholtz, David A, Greenhalgh, Roger, Edwards, Sarah J L
Format Journal Article
LanguageEnglish
Published London British Medical Journal Publishing Group 01.01.2000
British Medical Association
BMJ Publishing Group LTD
BMJ Publishing Group
British Medical Journal
EditionInternational edition
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Evaluating treatments is difficult when developments or variants arise frequently. In these circumstances randomized controlled trials should not await stability, but should track progress over time, providing unbiased comparisons at each stage.
Bibliography:href:bmj-320-43.pdf
Correspondence to: D A Braunholtz
istex:357DE7D18C4DDA2753812DA0296E1C7ABA6F94B1
ark:/67375/NVC-V8K6P6PB-K
PMID:10617532
ArticleID:bmj.320.7226.43
local:bmj;320/7226/43
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Correspondence to: D A Braunholtz D.A.Braunholtz@Bham.ac.uk
ISSN:0959-8138
0959-8146
1468-5833
1756-1833
DOI:10.1136/bmj.320.7226.43